{
    "2021-11-02": [
        [
            {
                "time": "",
                "original_text": "益丰药店(603939)2021年三季报点评：无惧短期波动 聚焦拓展+新零售战略蓄力远航",
                "features": {
                    "keywords": [
                        "益丰药店",
                        "2021年三季报",
                        "短期波动",
                        "聚焦拓展",
                        "新零售战略"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "财信证券：给予益丰药店买入评级，目标价位63.5元",
                "features": {
                    "keywords": [
                        "财信证券",
                        "益丰药店",
                        "买入评级",
                        "目标价位"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}